Insiders' Blog
Thoughts on hot market topics from the staff at StreetInsider.com
More Insiders' Blog
View Older Stories View Newer Stories-
Vringo (VRNG) Volatility Elevated, Shares Added to Russell Microcap Index
-
Nokia (NOK) Continues Getting Hit as Windows Phone Demand Questioned Again
-
Amyris (AMRS) Volatility Up as Shares Get Above Key Activty Level
-
Sector Security, Juicy Dividend Yield Make Corrections Corp. (CXW) One to Watch - Barron's
-
Hovnanian Enterprises (HOV) Volaility Up Following Home Sales Data; Shares Swing
-
Bristol-Myers (BMY), Pfizer (PFE) See $5B of Market Cap Evaporate Following CRL on ELIQUIS
-
Arena (ARNA) Snubs Downgrade, Now Higher on the Session
-
JPMorgan (JPM) to Shift CIO Management, But Will Stay Risky Course
-
Disney's (DIS) Pixar Bats 1.000 with New Release; 'Madagascar Mania' Fades
-
Tide Going Out on BRICs
-
Another Bear Roars at Arena (ARNA); Says Numbers, Potential Overblown
-
China Real Estate Growth Seen as Savior, But Could Be the Devil in Disguise
-
First Poll on Microsoft (MSFT) Surface Pricing Evokes Expected Response
-
First Solar (FSLR) Shares Higher, But Might Have More Upside in Store...
-
Polycom (PLCM) Volatility Up as Shares Continue Seeing Pressure
-
General Motors (GM) Moves to Intraday Lows Following Large Chevy Cruze Recall
-
J&J (JNJ) Has Solid Defense as Offense Begins Falling into Place - Barron's
-
Pick Up Dividend Payers with Juicy Yields Near Annual Lows (NOK) (FCX) (MT) (More...)
-
Arena-Mania (ARNA) Takes Center Stage and Everyone Has an Opinion
-
UPDATE: BioMimetic Therapeutics (BMTI) Sees Upside on Stronger Volume
-
Facebook's (FB) New Feature Will Allow Comment Editing
-
Alexza Pharma (ALXA) Volatility Up; Shares Rip Higher on ADASUVE NDA Resubmission
-
Short Seller Attacks Evergrande Group in China
-
Arena Pharmaceuticals (ARNA) Shares Well into Red Territory Early
-
Facebook (FB) U.S. Uniques Slip in May...Maybe...
-
They're Here! - Tesla Motors' (TSLA) Model S Arrives
-
Navistar (NAV) Could Get Bids, But Some Big Hurdles Remain...
-
Protalix BioTherapeutics (PLX) Hit as EMA CHMP Denies MAA for Taliglucerase Alfa
-
First Prices for Microsoft's (MSFT) Surface Leak, Could Be Competitive
-
Navistar (NAV) Could Be in Talks with Investment Banks Over Options
-
Best Buy (BBY) Shareholder Meeting Full of Empty Promises, Little Else
-
Goldman Tells the Suicidal Man to "Jump"
-
Iran Accuses U.S. of "Massive Cyber Attack"
-
Coal Plants Shuddered in Jersey, Layoffs at Arch Coal (ACI), Industry in Shambles
-
Spain Needs $78B for Financial System to Stay Solvent - Consultants
-
Apple (AAPL) Employees are Livin' Large with Bigger Paychecks, Better Discounts
-
Philly Fed Sheds Light on Gloomy Manufacturing Activity
-
$6 Billion Loss Estimated as London Whale Story Enters Final Chapter
-
Capital One (COF) Gets Most Complaints, According to New CFPB Data; Shares Slump
-
Quicksilver Resources (KWK) Volatility, Shares Rise Following Nat Gas Data, Hot Weather Outlook
-
Disaster Averted: Facebook (FB) Not the Worst IPO Ever; Burger King (BKW) Still Sizzles
-
Microsoft's (MSFT) New Tablet Could Change PC Landscape...for Good or Bad
-
Pfizer (PFE) Ticks Higher on Expanded Lyrica Indication
-
Key Energy (KEG) Slammed Following Q2 Outlook Cut
-
Early Arena Pharma (ARNA) Volume Exceeds 1M Mark; Stock Continues Higher
-
Eagle Bulk (EGLE) Strongly Higher Following Credit Amendments
-
Oracle (ORCL) CEO Goes Long on Pineapples
-
Initial Claims Fall Less than Expected to 387K as Fed Continues Operation Twist
-
Apple's (AAPL) iPhone 5 Likely to Be "True World Phone" and Compatible with China Mobile - Analyst
-
Let's Be Honset, Microsoft (MSFT) Just Doesn't Care About Nokia (NOK) Anymore
